Thymosin Beta 4 has been investigated for the treatment of STEMI, Dry Eye, Diabetes, Pressure Ulcers, and Dry Eye Syndrome, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.